Mosaic Family Wealth, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mosaic Family Wealth, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$448,000
-7.1%
91,3140.0%0.12%
-10.8%
Q2 2021$482,000
+10.0%
91,3140.0%0.14%
+9.4%
Q1 2021$438,000
+10.1%
91,314
-0.5%
0.13%
-4.5%
Q4 2020$398,000
+4.5%
91,807
-0.6%
0.13%
-7.0%
Q3 2020$381,000
+60.1%
92,357
-0.7%
0.14%
+45.9%
Q2 2020$238,000
-10.2%
92,997
+1.3%
0.10%
-26.9%
Q1 2020$265,000
-23.4%
91,814
+0.5%
0.13%
-3.6%
Q4 2019$346,000
-43.2%
91,3140.0%0.14%
-44.6%
Q3 2019$609,000
+7.6%
91,3140.0%0.25%
+5.9%
Q2 2019$566,000
-12.8%
91,3140.0%0.24%
-9.2%
Q1 2019$649,000
-16.8%
91,3140.0%0.26%
-18.9%
Q4 2018$780,000
-25.9%
91,3140.0%0.32%
-25.1%
Q3 2018$1,052,000
-55.4%
91,3140.0%0.43%
-51.8%
Q2 2018$2,359,000
+8.1%
91,3140.0%0.89%
+10.7%
Q1 2018$2,182,000
-33.8%
91,314
-6.2%
0.81%
-32.8%
Q4 2017$3,298,000
+26.3%
97,314
-21.1%
1.20%
+18.5%
Q3 2017$2,611,000
+21.0%
123,3140.0%1.01%
+12.6%
Q2 2017$2,157,000
-0.0%
123,3140.0%0.90%
-3.6%
Q1 2017$2,158,000
+3.6%
123,3140.0%0.93%
-2.7%
Q4 2016$2,084,000
+3.0%
123,3140.0%0.96%
+2.1%
Q3 2016$2,024,000
+8.4%
123,3140.0%0.94%
+4.1%
Q2 2016$1,867,000
+4.7%
123,3140.0%0.90%
+5.4%
Q1 2016$1,783,000123,3140.86%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 657,467$2,709,0002.82%
Healthcare Value Capital, LLC 100,000$412,0001.36%
Opaleye Management Inc. 1,487,800$6,130,0001.20%
Worth Venture Partners, LLC 225,106$927,0000.76%
ARMISTICE CAPITAL, LLC 2,742,000$11,297,0000.41%
DELTEC ASSET MANAGEMENT LLC 355,845$1,466,0000.26%
ESSEX INVESTMENT MANAGEMENT CO LLC 329,437$1,357,0000.19%
Mosaic Family Wealth, LLC 92,357$381,0000.14%
EMERALD ADVISERS, LLC 642,226$2,646,0000.11%
DCF Advisers, LLC 31,236$129,0000.07%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders